Description
A modulator of HBV capsid assembly; reduces viral DNA load in HBV-infected HepG2.2.15 cells (EC50 = 121 nM) without affecting cell growth; reduces viral DNA load in primary human hepatocytes infected with the HBV genotypes Ae, Bj, C, and D (EC50s = 101, 240, 119, and 200 nM, respectively); prevents formation of covalently closed circular DNA in HBV-infected primary human hepatocytes in a concentration-dependent manner when administered in combination with the HBV viral inoculum; reduces plasma HBV DNA content in HBV-infected humanized mice at 200 mg/kg per day ,
Formal name: N-(4-fluoro-3-methylphenyl)-3-[[[(3S)-tetrahydro-3-furanyl]amino]sulfonyl]-benzamide
Synonyms:
Molecular weight: 378.4
CAS: 1572510-42-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|Hepatitis